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Abstract
Background: Despite advances in survival in patients with thalassemia major (TM) the most
common cause of death is cardiac disease. Regular cardiac follow-up is imperative in order to
identify and reverse pathology. Cardiac Magnetic Resonance (CMR) and Echocardiography (US) are
applied in parallel to TM patients for cardiac evaluation and ongoing monitoring. A comparison
between mutual features would be useful in order to assess the accuracy and reliability of the two
methods, with a particular focus on routine US application. TM's special attributes offer an
excellent opportunity for cardiac imaging research that has universal general purpose applications.
Methods: 135 TM patients underwent US (Teichholz's M-mode formula – rapidly accessible means
of measuring volumes and ejection fraction) and CMR volumetry. Paired-samples t-test, Passing &
Badlock regression and Bland & Altman plot were used while comparing the common parameters
between the CMR and the US.
Results: We found that the US volumes were underestimated, especially the end-diastolic volume
(p < 0.001). The end-systolic volume showed a borderline two-tailed probability (p ≈ 0.05). The
correlation for the ejection fraction was acceptable (r = 0.60) without a statistically significant
difference (p = 0.37) and the Bland Altman plot range was narrow (25.8%). There was a satisfactory
correlation of the US' shortening fraction with CMR's ejection fraction (r = 0.58).
Conclusion: In cases where cardiac wall movement abnormalities are absent, the US Teichholz's
M-mode formula for volume measurements, though less sophisticated in comparison to the high
resolution CMR technique, offers an adequate ejection fraction estimation for routine use,
especially when monitoring gross alterations in cardiac function over time, and is easy to perform.
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Background
Patients with homozygous, transfusion dependent tha-
lassemia (TM) exhibit a broad spectrum of cardiac pathol-
ogy due to the nature of their disease. Methods of cardiac
imaging, such as the US and CMR, assess cardiac function
in thalassemia major and estimate the extent of damage.
Having in mind the special attributes of this patient pop-
ulation and their need for frequent evaluation of heart
performance and cardiac iron load with US and CMR [1],
TM offers an excellent opportunity for cardiac imaging
research that has universal general purpose applications.
Echocardiography (US) is a very useful examination since
its application is widespread, safe, economical and very
commonly used in every day medical practice. However
the image acquisition depends on the operator and the
acoustic window [2]. Reproducibility is reasonable in nor-
mal ventricles [3], but the quantifications of volumes and
mass rely on geometrical assumptions that do not apply
to ventricles undergoing asymmetric cardiac remodelling
such as in cardiomyopathy [4,5] (presence of asynergy
and dilatation).
The most recent advance in cardiac imaging is with Car-
diac Magnetic Resonance (CMR). Like echocardiography,
it is free of ionizing radiation, non-invasive and reliable.
In addition it's independent of geometric assumptions
[6,7] and has been shown to be accurate [8,9] and repro-
ducible [10-19]. However, unlike echocardiography, it is
expensive (up to over 5 times the cost of US) [20,21], time
consuming, performed within a claustrophobic environ-
ment and cannot be used in patients with cardiac pace-
makers or metallic implants in their upper torso. It is also
not universally available.
Considering the above, a comparison between mutual
features would be useful in order to assess the accuracy
and reliability of the two methods, with a particular focus
on routine US application. From the common measured
left ventricle (LV) parameters in both techniques the end-
diastolic volume (EDv), the end-systolic volume (ESv),
the stroke volume (Sv) and, most importantly, the ejec-
tion fraction (EF) are very important in assessing the over-
all heart performance and help classify patients in
condition related risk groups.
Methods
One hundred and thirty five (135) patients with TM
attending an outpatient clinic, regularly transfused at
approximately two weekly intervals and with regular che-
lation therapy, were assessed with CMR and had ultra-
sound cardiac assessment within an interval of 1 month
from their CMR (prior or later). There were 72 females
and 63 males with a mean age of 29.96 (± 5.91) years. The
mean body surface area was 1.66 (± 0.17) m2 and the
mean heart rate was 78.81 (± 10.34) beats per minute.
Patients in whom cardiac medication was introduced
between studies were excluded from the comparison anal-
ysis, due to the possible influence with either study's
results.
Echocardiography (US)
Complete M-mode, two-dimensional and Doppler
(pulsed-wave, continuous-wave and color) echocardiog-
raphy was performed at rest, using an Aloca ProSound
SSD 5500 ultrasound system (Aloca Co., Tokyo, Japan).
Patients were examined in the mid-interval between two
scheduled transfusions. The same applied for the CMR
study. All echocardiographic and Doppler studies were
carried out by the same observer (AA). Chamber dimen-
sions were measured according to the recommendations
of the American Society of Echocardiography (ASE) [22]
using M-mode echocardiography, while two-dimensional
echo was used wherever M-mode measurements were
considered unreliable [23,24]. Stroke volume, ejection
fraction and cardiac output estimation were based on the
calculation of LV end-diastole and end-systole volumes
with Teichholz's formula, based on the most accurate and
easily performable M-mode measurement algorithm
[4,5]:
V = [7/(2.4 + LVId)]·[LVId]3, with LVId being the LV inter-
nal dimension (end-diastole and end-systole respec-
tively).
Cardiovascular Magnetic Resonance (CMR)
A cardiac-dedicated 1.5 Tesla MR imager (Signa CVI, Gen-
eral Electric, Milwaukee, USA) with 40 mT/m gradients,
phase array-cardiac rf coil and appropriate cardiac soft-
ware was used for the CMR measurements. Cardiac vol-
umes and ejection fractions were calculated offline in GE's
"Advantage Windows" Workstation using GE's proprie-
tary software MASS_PLUS. GE's algorithm for calculating
cardiac volumes is based on a 3D method (in essence the
drawn area of endocardium and exocardium of each
short-axis slice multiplied by slice thickness and stacked
together to create a 3-dimensional object). Additional
imaging parameters included a single excitation, a matrix
of 224 × 224, bandwidth of 125 kHz, slice thickness of 8
mm, and electrocardiogram (ECG) gating. Each slice in 2-
chamber, 4-chamber and short-axis view was acquired in
a single breath-hold (15–20 sec), with a 20 phases per car-
diac cycle. Cardiac volumes, and thereby ejection fraction
and stroke volume, were assessed from 10–12 short-axis
slices from the base to the apex of the heart. Although
automation worked quite well, manual corrections had to
be made occasionally in order to ensure the accuracy of
the measurements. All measurements were performed by
the same operator (EG). The unit was validated through
the Brompton site with five patients who had CMR, onceCardiovascular Ultrasound 2007, 5:24 http://www.cardiovascularultrasound.com/content/5/1/24
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in Athens, then London then again in Athens all within a
three week period and showed that the reproducibility
was within a 5% confidence [25]. In sum, the 3D-Recon-
struction volume calculation formula could be outlined as
follows:
V = (A1 + A2 + A3 + ... + An) × 8 mm, with A1 to An being the
area of each of the 10–12 short-axis slices
Statistical analysis
Statistical analysis was performed with MedCalc™ (Med-
Calc Software, Mariakerke, Belgium) using paired-sam-
ples t-test, Passing & Badlock regression and Bland &
Altman plot when comparing the common features
between the CMR and the US. The p values were regarded
as significant when <0.05. Continuous variables are
expressed as mean ± 1 SD. For correlation, r > 0.5 was con-
sidered significant.
The Institutional Review Board approved the study and all
subjects signed written consent for the anonymous publi-
cation of their data.
Results
Table 1 demonstrates CMR (a) and US (b) LV parameters
of the patients with mean values and standard deviations.
Table 2 demonstrates the CMR/US methods comparison
by Passing & Badlock regression, paired samples t-tests
and Bland & Altman (BA) plot. The best correlation was
with the net volumes (r from 0.78 to 0.81). However, the
US volumes were relatively underestimated, especially the
end-diastolic volume. This explains the statistically signif-
icant difference (paired samples t-test) for the end diasto-
lic volume (MREDv – USEDv, p < 0.001), whereas the end
systolic volume showed a borderline two-tailed probabil-
ity (MRESv – USESv, p ≈ 0.05). The correlation for the
ejection fraction was acceptable (MREF – USEF, r = 0.60)
without a statistically significant difference (t-test p =
0.37) and the Bland Altman plot range was narrow
(25.8%). This is explained by the relatively equivalent
underestimates of the net volumes. Equally satisfactory
was the correlation of the US' shortening fraction (USSF)
with CMR's ejection fraction (MREF) (r = 0.58).
Figures 1A, 1C, 1E and 1G show the Passing & Badlock
scatter diagrams and regression lines for the paired param-
eters. Figures 1B, 1D, 1F and 1H are the Bland & Altman
plots for the paired parameters. Figure 1I shows the scatter
diagram and regression line for USSF correlated to MREF.
The Cusum test in all Passing & Badlock regression analy-
ses showed no significant deviations from linearity.
Discussion
For this study we used information from a large number
of patients (135 in total) who had undergone a CMR
examination for follow-up on their cardiac iron overload
(T2* score) in parallel to their routine echocardiogram.
The US technique employed by our research team did not
implement latest technological advances and measure-
ments were calculated with a relatively simple algorithm
in order to evaluate one of the most common and rapidly
accessible means of measuring EF via US against the high
resolution CMR technique.
Our study demonstrated a mild discrepancy of values in
the net volume (diastolic and systolic) comparison, with
the US derived measurements being relatively and system-
atically underestimated. However this consistent underes-
timation was proportionally equal within the diastolic
Table 2: CMR/US methods comparison by Passing & Badlock regression analysis, paired samples t-tests and Bland & Altman (BA) 
plot.
CMR – US EDv (ml) ESv (ml) Sv (ml) EF (%) EF – SF (%)
Mean diff ± SD 11.22 ± 26.03 2.80 ± 12.41 8.25 ± 19.79 0.59 ± 6.60 -
p (t-test) 0.0003 0.0514 (NS) 0.0005 0.3684 (NS)-
r (p < 0.0001) 0.8135 0.8081 0.7763 0.5990 0.5771
BA limits -39.8 to 62.2 -21.5 to 27.1 -30.5 to 47.0 -12.3 to 13.5 -
BA range 102.0 48.6 79.7 25.8 -
Table 1: CMR (a) and US (b) parameters of the patients with 
mean values and standard deviations.
a) CMR LV parameters Mean ± SD
MREDv – End-Diastolic volume (ml) 138.02 ± 42.98
MRESv – End-Systolic volume (ml) 45.51 ± 21.05
MRSv – Stroke volume (ml) 92.51 ± 29.69
MREF – Ejection fraction (%) 67.09 ± 7.88
b) US LV parameters Mean ± SD
USEDv – End-Diastolic volume (ml) 123.98 ± 26.48
USESv – End-Systolic volume (ml) 41.05 ± 14.59
USSv – Stroke volume (ml) 82.70 ± 16.51
USSF – Shortening fraction (%) 37.38 ± 4.80
USEF – Ejection fraction (%) 66.87 ± 6.39Cardiovascular Ultrasound 2007, 5:24 http://www.cardiovascularultrasound.com/content/5/1/24
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1A-1H. Passing & Badlock scatter diagrams and regression lines, and Bland & Altman plots for the compared parameters Figure 1
1A-1H. Passing & Badlock scatter diagrams and regression lines, and Bland & Altman plots for the compared parameters. 1I. 
Scatter diagram and regression line for the USSF-MREF correlation. USEDv: US LV End-Diastolic volume. MREDv: CMR LV 
End-Diastolic volume. USESv: US LV End-Systolic volume. MRESv: CMR LV End-Systolic volume. USSv: US LV Stroke volume. 
MRSv: CMR LV Stroke volume. USEF: US LV Ejection fraction. MREF: CMR LV Ejection fraction. USSF: US LV Shortening frac-
tion.Cardiovascular Ultrasound 2007, 5:24 http://www.cardiovascularultrasound.com/content/5/1/24
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and systolic volume calculations leading to extremely sim-
ilar ejection fractions between the two methods.
In two studies by Bellenger et al [26,27] where a compar-
ison of left ventricular function measurements was made
in patients (21 and 12 respectively) who had undergone
orthotopic cardiac transplantation, results demonstrated
statistically significant difference with systematic US over-
estimation of the ejection fraction while comparing CMR
to US in both studies (t-test 2.7 ± 6.3% with p < 0.01 in
the first study and t-test 7.7 ± 5.9% with p < 0.001 in the
second). A poor correlation for the same parameter was
also observed (r = 0.41 and r = 0.3 respectively). Regarding
the obtained BA plots for the ejection fraction, both stud-
ies showed ranges similar to ours (24.6% and 24%
accordingly), but the limits defining these ranges were
more asymmetric in comparison to ours (-9.6 to 15% and
-4 to 20% respectively). The contrast in findings between
our study and the previous two may be due to the use of a
different technique while assessing cardiac volumes with
US (Teichholz's vs. cube formula [28]), the relative dis-
proportion in sample size (135 vs. 12) and/or the diver-
sity of each study's patients' age (young vs. older adults)
and heart condition (iron-infiltrative disease vs. immuno-
logic response and heart remodelling following cardiac
transplantation). In the present study, the patients were
relatively young, thus a good acoustic window was
achieved during their US evaluation. In addition, none of
them suffered from segmental hypokinesias of the myo-
cardium, minimizing the possible bias that such altera-
tions might introduce in the comparison analysis. It is
essential for the Teichholz formula that such cardiac wall
movement disorders are not present and a good acoustic
window is obtained.
An earlier study by the same research team [29] in a cardi-
ovascular clinic compared ejection fraction measurements
via CMR and US (using both the cube and Teichholz for-
mulae). Each of the two paired technique comparisons
involved 22 patients. The correlation between CMR and
both US techniques was 0.6. For CMR versus the cube and
Teichholz formulae the BA limits were wide (-29.9 to
17.6% with a range of 47.5% and -20.6 to 23.3% with a
range of 43.9% respectively). Additionally, the cube for-
mula overestimated the ejection fraction (6.1 ± 12.1%)
and differed with a statistical significance from CMR (t-
test p < 0.05), while on the other hand Teichholz's for-
mula underestimated the same parameter (1.3 ± 11.2%)
and t-test showed no statistically significant difference
from CMR. Our study's outcomes accord the results of the
latter comparison (CMR – Teichholz) and furthermore
demonstrate a better agreement between CMR and US
(BA range of 25.8% vs. 43.9%). Therefore Teichholz's
easy-to-use formula is definitely sufficient for the everyday
practice. This fact allows echocardiography, despite the
slight underestimation observed, to assume a particularly
useful role in cases where a reliable determination of EF is
promptly needed, and provided that cardiac wall motility
is normal.
In the present study, due to patients' intolerance to multi-
ple evaluations and significant examination cost, particu-
larly CMR's, we were unable to perform an interstudy
reproducibility analysis of both methods. We do believe
however that this represents a small limitation to this
work.
Conclusion
The good correlation and the lack of statistically signifi-
cant difference between the measurements of the two
techniques for ejection fraction indicate that both meth-
ods are accurate and interchangeable for that assessment.
In cases where application requirements described are
met, the US Teichholz's M-mode formula for volume
measurements, though less sophisticated in comparison
to the high resolution CMR technique, offers an adequate
EF estimation for routine use, especially when monitoring
gross alterations in cardiac function over time, and is easy
to perform, in contrast to the not always readily available
CMR technique.
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